Bohai Pharmaceuticals to Present at the Rodman & Renshaw Annual Global Investment Conference

NEW YORK and YANTAI, Shandong Province, China, Sept. 7, 2011 (GLOBE NEWSWIRE) -- Bohai Pharmaceuticals Group, Inc. (OTCBB:BOPH) (OTCQB:BOPH), a China-based pharmaceutical company engaged in the production, manufacturing and distribution of modernized Traditional Chinese Medicine (TCM) in China, today announced that Gene Hsiao, Chief Financial Officer, will present at the Rodman & Renshaw Annual Global Investment Conference on Monday, September 12, 2011 at the Waldorf-Astoria hotel in New York. Mr. Hsiao is scheduled to present at 10:25 a.m. Eastern Time.

Investors or analysts who are interested in the company may conduct one-on-one meeting with management at the conference by contacting the Rodman & Renshaw conference team.

About Rodman & Renshaw

Rodman & Renshaw is a full-service investment bank dedicated to providing corporate finance, strategic advisory and related services to public and private companies across multiple sectors and regions. Rodman also provides research and sales and trading services to institutional investors. Rodman is the leader in the PIPE (private investment in public equity) and RD (registered direct offering) transaction markets. According to Sagient Research Systems, Rodman has been ranked the #1 Placement Agent in terms of deal volume of PIPE and RD financing transactions completed every year since 2005.

About Bohai Pharmaceuticals Group

Bohai Pharmaceuticals Group, Inc. (OTCBB:BOPH) (OTCQB:BOPH) is engaged in the production, manufacturing and distribution of herbal pharmaceuticals based on Traditional Chinese Medicine in China.  Bohai's medicines address common health problems such as rheumatoid arthritis, viral infections, gynecological diseases, cardio vascular issues and respiratory diseases. Bohai's products are sold either by prescription through hospitals or over-the-counter through local pharmacies and retail drug store chains. Bohai has approximately 600 employees, including approximately 300 sales representatives, operating from 20 offices throughout China.  Bohai's three lead products, Tongbi Capsules, Tongbi Tablets and Lung Nourishing Cream, are eligible for reimbursement under China's National Medical Insurance Program.

For more information, please visit the Company's website at www.bohaipharmaceutical.com.

CONTACT: David Waldman or Vivian Huo
         Crescendo Communications, LLC
         Boph@crescendo-ir.com
         Tel: (212) 671-1020
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.